COMMUNIQUÉS West-GlobeNewswire
-
BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023
24/04/2024 - 07:00 -
Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l'exercice 2024
24/04/2024 - 07:00 -
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
24/04/2024 - 07:00 -
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
24/04/2024 - 07:00 -
Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
24/04/2024 - 03:36 -
Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
23/04/2024 - 22:30 -
Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
23/04/2024 - 22:30 -
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
23/04/2024 - 23:00 -
Smart for Life Announces the Successful Completion of Restructuring Program
23/04/2024 - 23:30 -
BioSyent to Attend Planet MicroCap Showcase
23/04/2024 - 23:45 -
Green Water Labs to Host Community Clean-Up Event in Celebration of Earth Day 2024
24/04/2024 - 00:23 -
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
23/04/2024 - 19:42 -
OrthoSelect announces Partnership with Relu to provide automated CBCT integration for DIBS AI software
23/04/2024 - 19:50 -
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
23/04/2024 - 21:56 -
Pennant Announces First Quarter 2024 Earnings Release and Call
23/04/2024 - 22:02 -
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
23/04/2024 - 22:05 -
ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024
23/04/2024 - 22:05 -
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
23/04/2024 - 22:05 -
Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024
23/04/2024 - 22:05
Pages